1-((Dimethylamino)methyl)cyclopropanecarboxylic acid hydrochloride

Catalog No.: 
ACNPBM926
CAS No.: 
1803603-95-3
Molecular Formula: 
C7H14ClNO2
Molecular Weight: 
179.65
1-((Dimethylamino)methyl)cyclopropanecarboxylic acid hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$302.00InquiryInquiry
100mg98%$437.00InquiryInquiry
250mg98%$616.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-((Dimethylamino)methyl)cyclopropanecarboxylic acid hydrochloride
IUPAC Name1-((dimethylamino)methyl)cyclopropane-1-carboxylic acid hydrochloride
MDL No.MFCD28383931
Molecular FormulaC7H14ClNO2
Molecular Weight179.65
SMILESO=C(O)C1(CC1)CN(C)C.[H]Cl
InChI KeyUJMJOIBZYCATSI-UHFFFAOYSA-N
Synonym1-[(dimethylamino)methyl]cyclopropane-1-carboxylic acid hydrochloride;1-((dimethylamino)methyl)cyclopropanecarboxylic acid HCl;1-[(Dimethylamino)methyl]cyclopropanecarboxylic Acid Hydrochloride
CAS No.1803603-95-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACNPBM926 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNPBM926 route product structure diagram
    ACNPBM9261803603-95-3
Inquiry

2. ACNPBM926 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNPBM926 route product structure diagram
    ACNPBM9261803603-95-3
Inquiry

3. ACNPBM926 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNPBM926 route product structure diagram
    ACNPBM9261803603-95-3
Inquiry

Comments (0)